Pharmaceutical & Biotechnology
FORUS Therapeutics
About this employer
FORUS Therapeutics is a Canadian biopharmaceutical company in Oakville, ON, dedicated to advancing novel medicines for hematologic malignancies and other cancers. A wholly owned subsidiary of PharmaEssentia Corp., it received Health Canada authorization in 2026 for BESREMI (ropeginterferon alfa-2b) to treat adults with polycythemia vera.